🔎 Trials Near Me

Domov › Srčno popuščanje › Colorado

Klinične študije za Srčno popuščanje v Colorado

23 študij za Srčno popuščanje išče udeležence na lokacijah v Colorado.

Mesta v Colorado

Uradno besedilo študije (angleško)

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

  • Research Site, Aurora
Vključevanje udeležencevFaza 3
Starost 18–130 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06307652

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

  • Univ of Colorado at Denver, Aurora
Vključevanje udeležencevFaza 2
Starost 40–84 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06979362

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

  • Research Site, Colorado Springs
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07761117

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

  • Rocky Mountain Regional VA Medical Center, Aurora
Vključevanje udeležencevFaza 3
Starost 18–85 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06736574

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

  • Research Site, Aurora
  • Research Site, Englewood
Vključevanje udeležencevFaza 3
Starost 40 in več · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT06677060

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

  • CON-10001, Aurora, CO, Aurora
  • CON-10005, Denver, CO, Denver
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT06024746

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

  • Aurora, CO Investigative Site 10001, Aurora
  • Denver, CO Investigative Site 10005, Denver
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT06008197

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

  • Children's Hospital Colorado ( Site 0012), Aurora
Vključevanje udeležencevFaza 2/3
29 Days – 17 Years · Vsi spoli · Posodobljeno 28. avg. 2026 · NCT05714085

Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver

  • Denver Health and Hospital Authority, Denver
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 26. avg. 2026 · NCT07435662

Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs

  • Children's Hospital Colorado, Aurora
Vključevanje udeležencevOpazovalna študija
Do 18 let · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT06532890

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

  • Aurora
  • Centennial
  • Colorado Springs
  • in še 1
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT00271180

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • Univ of Colorado at Denver, Aurora
  • VA Eastern Colorado Health Care System, Aurora
  • Intermountain Heart & Vascular, Denver
  • in še 1
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT07567001

Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure

  • University of Colorado, Aurora
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 13. jul. 2026 · NCT06526988

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

  • FIN-10110, Aurora, CO, Aurora
  • FIN-10001, Aurora, CO, Aurora
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 10. jul. 2026 · NCT06033950

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

  • Children's Hospital Colorado - Anschutz Medical Campus - Cardiology, Aurora
Vključevanje udeležencevFaza 3
Do 18 let · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT07192952

A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction

  • Children's Hospital Colorado - Anschutz Medical Campus - Cardiology, Aurora
Vključevanje udeležencevFaza 3
6 Months – 17 Years · Vsi spoli · Posodobljeno 15. jun. 2026 · NCT07188805

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

  • South Denver Cardiology, Littleton
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 13. apr. 2026 · NCT03142152

Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization

  • Boulder Heart, Boulder
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 13. apr. 2026 · NCT07224906

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  • Barbara Davis Center / University of Colorado Denver, Aurora
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 24. mar. 2026 · NCT06217302

Left vs Left Randomized Clinical Trial

  • University of Colorado (Anschutz Medical Campus), Denver
  • South Denver Cardiology Associates, Littleton
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2025 · NCT05650658

Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC

  • University of Colorado - Anschutz Medical Campus, Aurora
Vključevanje udeležencevFaza 1
Starost 18–65 · Vsi spoli · Posodobljeno 6. feb. 2025 · NCT06228924

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.